Key result
Assessment of maternal cardiovascular parameters at 35-37 weeks' gestation did not substantially improve the screening performance for SGA or LGA neonates provided by maternal factors and fetal biometry.
Why the study?
Do maternal cardiovascular parameters at 35-37 weeks' gestation improve the prediction of SGA and LGA neonates?
Observational (n=2,835)
Do maternal cardiovascular parameters at 35-37 weeks' gestation improve the prediction of SGA and LGA neonates?
p-value: p=0.0095
Maternal cardiovascular parameters at 35-37 weeks' gestation correlate with birth weight but do not substantially improve the clinical prediction of SGA or LGA neonates beyond standard maternal factors and fetal biometry.
Maternal CV parameters correlate with birth weight but should not yet inform SGA/LGA screening; leaves open hemodynamic influences on fetal growth.
OBJECTIVE: To evaluate the relationship between maternal cardiovascular parameters and neonatal birth weight and examine the potential value of these parameters in improving the prediction of small-for-gestational-age (SGA) and large-for-gestational-age (LGA) neonates provided by maternal characteristics and medical history. METHODS: In 2835 singleton pregnancies maternal characteristics and medical history were recorded and maternal cardiovascular parameters were measured. The observed measurements of cardiovascular parameters were expressed as multiples of the normal median (MoM) values after adjustment for those characteristics found to provide a substantial contribution to their measurement. Regression analysis was used to determine the significance of association between the normalized values of the cardiovascular parameters with birth-weight Z-score. Multivariable logistic regression analysis was then used to determine if the maternal factors, fetal biometry and maternal cardiovascular parameters had a significant contribution to predicting SGA and LGA neonates. The performance of screening was determined by the area under receiver-operating characteristics curves (AUC). RESULTS: In the study population there were significant positive associations between maternal cardiac output and heart rate with neonatal birth-weight Z-score, and significant negative associations between total peripheral resistance and mean arterial pressure (MAP) with neonatal birth-weight Z-score. In pregnancies delivering SGA neonates (n = 249 (8.8%)), cardiac output and heart rate were lower and total peripheral resistance and MAP were higher, whereas in pregnancies delivering LGA neonates (n = 292 (10.3%)) cardiac output and heart rate were higher and total peripheral resistance and MAP were lower. The performance of screening for delivery of SGA neonates achieved by maternal characteristics and fetal biometry was not improved by the measurement of maternal cardiovascular parameters. There was a small but significant improvement in the performance of screening for delivery of LGA neonates by maternal factors and fetal biometry with the addition of maternal heart rate (comparison of AUC, P = 0.0095). CONCLUSIONS: There are significant associations between maternal cardiac output, heart rate, total peripheral resistance and MAP and neonatal birth-weight Z-score; such findings reflect the close relationship between maternal cardiac function and fetal demands. However, assessment of these parameters at 35-37 weeks' gestation is unlikely to improve substantially the performance of screening for SGA or LGA neonates provided by a combination of maternal factors and fetal biometry.
No takes yet. Share an insight, caveat, or question.
Guy et al. (2016) conducted an observational in Singleton pregnancies (n=2,835). Maternal cardiovascular parameters (cardiac output, heart rate, total peripheral resistance, MAP) vs. Maternal characteristics and fetal biometry alone was evaluated on Prediction of small-for-gestational-age (SGA) and large-for-gestational-age (LGA) neonates (p=0.0095). Assessment of maternal cardiovascular parameters at 35-37 weeks' gestation did not substantially improve the screening performance for SGA or LGA neonates provided by maternal factors and fetal biometry.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: